Mutation screening in a Norwegian cohort with pheochromocytoma.
about
Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations.The emerging role and targetability of the TCA cycle in cancer metabolism.An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma.SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).
P2860
Mutation screening in a Norwegian cohort with pheochromocytoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Mutation screening in a Norwegian cohort with pheochromocytoma.
@en
Mutation screening in a Norwegian cohort with pheochromocytoma.
@nl
type
label
Mutation screening in a Norwegian cohort with pheochromocytoma.
@en
Mutation screening in a Norwegian cohort with pheochromocytoma.
@nl
prefLabel
Mutation screening in a Norwegian cohort with pheochromocytoma.
@en
Mutation screening in a Norwegian cohort with pheochromocytoma.
@nl
P2093
P2860
P1433
P1476
Mutation screening in a Norwegian cohort with pheochromocytoma.
@en
P2093
Eva Hofsli
Henrik Halvorsen
Lars F Engebretsen
Siri Bachke
Sture E Falkmer
Ursula G Falkmer
Wenche Sjursen
P2860
P2888
P304
P356
10.1007/S10689-013-9608-0
P577
2013-09-01T00:00:00Z